Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

GMP for API's Concept Paper

Wednesday the 8th February 2012

Dear All,

In late January 2012 the Commission published a Concept Paper on extending the scope of the current GMP Directive 2003/94/EC to cover APIs. The reason for this is proposal is given as the implementation of Directive 2011/62/EU and the need to bring a coherent approach across the EU. This proposal is thus being made to ensure that there is a ‘level playing field’ in the legal provisions relating to API GMP across the EU.

The Concept Paper proposes the following:

• “… all provisions in that Directive which currently address the manufacturing or manufacturer of medicinal products would also apply to the manufacturing and manufacturer of active substances.”
• However, some provisions will not apply to APIs:
o Marketing Authorisations
o Qualified Persons
o Manufacturing Authorisations

Adoption of the new Directive is planned for 2013. It is proposed that Member States will have just 6 months after the publication of a revised GMP Directive to transpose it into national law and it will have to be implemented just 3 months later.

Comments on the Concept Paper should be submitted by 20 April 2012.

Best regards,

Pete
Peter Gough, Partner
NSF-DBA Ltd.

Quick links

NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Boston and Ann Arbor, USA

A word from NSF Health Sciences

The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

© NSF Health Sciences 2014

Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: pharmamail@nsf.org
US Office: NSF Health Sciences, 6th floor, 129 South St, Boston, MA 02111 | Tel: 1-857-277-0060 | Fax: 1-857-284-7207 | Email: USpharma@nsf.org